Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Virchows Archiv : an International Journal of Pathology
|
August 27, 2016
ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization
Andrew S Williams, Wenda Greer, Drew Bethune, et al.
British Journal of Haematology
|
May 4, 2024
Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation
Signy Chow, Stephanie Lee, August Lin, et al.
Histopathology
|
September 27, 2024
MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer
Ekaterina Olkhov-Mitsel, Alexander Oberc, Kenneth J Craddock, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 1, 2012
Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent
Chris M J Conklin, Kenneth J Craddock, Cherry Have, et al.
American Journal of Clinical Pathology
|
March 22, 2026
Response to Methodological and reporting considerations for reflex FGFR testing in urinary tract carcinomas
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
American Journal of Clinical Pathology
|
October 16, 2025
Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
American Journal of Clinical Pathology
|
April 6, 2026
Response to Comment on "Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: a dual-institutional experience"
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
Cancer Medicine
|
February 6, 2024
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, et al.
Cancer Cytopathology
|
March 27, 2015
Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation
Gilda da Cunha Santos, Mauro Ajaj Saieg, Hyang Mi Ko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 17, 2015
A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer
Mahadeo A Sukhai, Kenneth J Craddock, Mariam Thomas, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Virchows Archiv : an International Journal of Pathology
|
August 27, 2016
ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization
Andrew S Williams, Wenda Greer, Drew Bethune, et al.
British Journal of Haematology
|
May 4, 2024
Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation
Signy Chow, Stephanie Lee, August Lin, et al.
Histopathology
|
September 27, 2024
MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer
Ekaterina Olkhov-Mitsel, Alexander Oberc, Kenneth J Craddock, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 1, 2012
Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent
Chris M J Conklin, Kenneth J Craddock, Cherry Have, et al.
American Journal of Clinical Pathology
|
March 22, 2026
Response to Methodological and reporting considerations for reflex FGFR testing in urinary tract carcinomas
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
American Journal of Clinical Pathology
|
October 16, 2025
Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
American Journal of Clinical Pathology
|
April 6, 2026
Response to Comment on "Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: a dual-institutional experience"
Ngoc-Nhu Jennifer Nguyen, Ekaterina Olkhov-Mitsel, Kenneth J Craddock, et al.
Cancer Medicine
|
February 6, 2024
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada
Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang, et al.
Cancer Cytopathology
|
March 27, 2015
Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation
Gilda da Cunha Santos, Mauro Ajaj Saieg, Hyang Mi Ko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 17, 2015
A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer
Mahadeo A Sukhai, Kenneth J Craddock, Mariam Thomas, et al.
Page
of 3